 Karina Serban
Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 11 | 2023 | 318 | 4.030 |
Why?
| | alpha 1-Antitrypsin | 7 | 2023 | 111 | 1.820 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 10 | 2022 | 1130 | 1.760 |
Why?
| | alpha 1-Antitrypsin Deficiency | 6 | 2022 | 78 | 1.690 |
Why?
| | Emphysema | 3 | 2021 | 122 | 1.620 |
Why?
| | Smoke | 4 | 2017 | 137 | 1.210 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 22 | 0.940 |
Why?
| | Somatomedins | 1 | 2022 | 27 | 0.880 |
Why?
| | Macrophages, Alveolar | 4 | 2021 | 355 | 0.860 |
Why?
| | Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2021 | 7 | 0.830 |
Why?
| | Complement C4 | 1 | 2021 | 25 | 0.820 |
Why?
| | Complement C1q | 1 | 2021 | 38 | 0.820 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 101 | 0.820 |
Why?
| | Prednisolone | 1 | 2021 | 76 | 0.810 |
Why?
| | Arthralgia | 1 | 2021 | 51 | 0.780 |
Why?
| | Exanthema | 1 | 2021 | 77 | 0.770 |
Why?
| | Tobacco Products | 3 | 2016 | 67 | 0.690 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 26 | 0.670 |
Why?
| | Blood Proteins | 1 | 2021 | 240 | 0.670 |
Why?
| | Metformin | 1 | 2021 | 293 | 0.620 |
Why?
| | Phagocytosis | 2 | 2021 | 360 | 0.560 |
Why?
| | Endocytosis | 2 | 2016 | 152 | 0.550 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 59 | 0.540 |
Why?
| | Proteomics | 1 | 2021 | 850 | 0.510 |
Why?
| | Endothelial Cells | 4 | 2023 | 717 | 0.450 |
Why?
| | Interleukin-6 | 1 | 2016 | 685 | 0.440 |
Why?
| | Disease Models, Animal | 4 | 2021 | 3676 | 0.440 |
Why?
| | Apoptosis | 2 | 2016 | 2461 | 0.350 |
Why?
| | Cigarette Smoking | 2 | 2022 | 79 | 0.340 |
Why?
| | Smoking | 4 | 2019 | 1478 | 0.340 |
Why?
| | Lung | 7 | 2023 | 3623 | 0.330 |
Why?
| | Lipopolysaccharides | 4 | 2023 | 857 | 0.280 |
Why?
| | Humans | 25 | 2023 | 118268 | 0.270 |
Why?
| | Mice | 10 | 2023 | 15446 | 0.260 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.240 |
Why?
| | Animals | 14 | 2023 | 33152 | 0.230 |
Why?
| | Caspase 3 | 2 | 2016 | 240 | 0.230 |
Why?
| | Endothelium | 1 | 2023 | 116 | 0.220 |
Why?
| | Pancreatic Elastase | 2 | 2022 | 63 | 0.210 |
Why?
| | Myosins | 1 | 2022 | 129 | 0.210 |
Why?
| | Vascular System Injuries | 1 | 2023 | 69 | 0.210 |
Why?
| | Endopeptidases | 1 | 2022 | 71 | 0.210 |
Why?
| | Cell Communication | 1 | 2023 | 279 | 0.210 |
Why?
| | Molecular Docking Simulation | 1 | 2022 | 101 | 0.210 |
Why?
| | Cell Death | 3 | 2019 | 336 | 0.210 |
Why?
| | Mice, Inbred C57BL | 5 | 2022 | 4887 | 0.200 |
Why?
| | Ligands | 1 | 2023 | 565 | 0.200 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 5 | 0.200 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 5 | 0.200 |
Why?
| | Receptors, Glucocorticoid | 1 | 2022 | 132 | 0.200 |
Why?
| | Lysophospholipase | 1 | 2021 | 12 | 0.200 |
Why?
| | Protease Inhibitors | 1 | 2022 | 101 | 0.200 |
Why?
| | Patient Care Management | 1 | 2021 | 57 | 0.200 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2021 | 23 | 0.200 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 106 | 0.200 |
Why?
| | Rituximab | 1 | 2021 | 153 | 0.190 |
Why?
| | PPAR gamma | 1 | 2022 | 187 | 0.190 |
Why?
| | Monocytes | 1 | 2023 | 511 | 0.190 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 168 | 0.190 |
Why?
| | Macrophages | 3 | 2022 | 1311 | 0.180 |
Why?
| | Glucosylceramides | 1 | 2019 | 7 | 0.180 |
Why?
| | Biomarkers | 2 | 2022 | 3568 | 0.180 |
Why?
| | Bronchodilator Agents | 1 | 2021 | 251 | 0.180 |
Why?
| | Immunologic Factors | 1 | 2021 | 224 | 0.170 |
Why?
| | Case-Control Studies | 2 | 2017 | 3156 | 0.170 |
Why?
| | Glycoproteins | 1 | 2021 | 317 | 0.170 |
Why?
| | Cells, Cultured | 5 | 2019 | 4044 | 0.170 |
Why?
| | Caspase 6 | 2 | 2016 | 5 | 0.170 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2019 | 22 | 0.170 |
Why?
| | Caspase 7 | 2 | 2016 | 22 | 0.170 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.160 |
Why?
| | Sphingolipids | 1 | 2018 | 59 | 0.160 |
Why?
| | Inflammation | 3 | 2023 | 2545 | 0.160 |
Why?
| | X-Ray Microtomography | 1 | 2018 | 79 | 0.160 |
Why?
| | Carbon Monoxide | 1 | 2018 | 64 | 0.160 |
Why?
| | ADAM17 Protein | 1 | 2017 | 31 | 0.150 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1379 | 0.150 |
Why?
| | Collagen | 1 | 2019 | 433 | 0.150 |
Why?
| | THP-1 Cells | 1 | 2016 | 19 | 0.140 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 78 | 0.140 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 196 | 0.140 |
Why?
| | Antiviral Agents | 1 | 2022 | 653 | 0.140 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 9 | 0.130 |
Why?
| | Pneumonia | 1 | 2021 | 579 | 0.130 |
Why?
| | Middle Aged | 4 | 2021 | 27514 | 0.130 |
Why?
| | Extracellular Matrix | 1 | 2019 | 444 | 0.130 |
Why?
| | Influenza, Human | 1 | 2021 | 553 | 0.130 |
Why?
| | Acute Lung Injury | 1 | 2018 | 278 | 0.130 |
Why?
| | Fibroblasts | 1 | 2019 | 835 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 605 | 0.120 |
Why?
| | Transcytosis | 1 | 2014 | 9 | 0.120 |
Why?
| | Alginates | 1 | 2014 | 51 | 0.120 |
Why?
| | Autoantibodies | 1 | 2021 | 1334 | 0.120 |
Why?
| | Pulmonary Alveoli | 1 | 2016 | 375 | 0.120 |
Why?
| | Rats | 3 | 2017 | 5339 | 0.110 |
Why?
| | Endothelium, Vascular | 2 | 2016 | 890 | 0.110 |
Why?
| | Prognosis | 1 | 2021 | 3425 | 0.110 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 193 | 0.110 |
Why?
| | Male | 7 | 2021 | 57479 | 0.110 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 309 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 1 | 2017 | 2434 | 0.100 |
Why?
| | Aging | 1 | 2021 | 1675 | 0.100 |
Why?
| | Acrospiroma | 1 | 2010 | 1 | 0.100 |
Why?
| | Sweat Gland Neoplasms | 1 | 2010 | 6 | 0.100 |
Why?
| | Genital Neoplasms, Male | 1 | 2010 | 6 | 0.100 |
Why?
| | Scrotum | 1 | 2010 | 25 | 0.100 |
Why?
| | Ceramides | 2 | 2023 | 96 | 0.090 |
Why?
| | Muscle, Smooth | 1 | 2011 | 157 | 0.090 |
Why?
| | Histoplasmosis | 1 | 2009 | 15 | 0.090 |
Why?
| | Female | 6 | 2021 | 61268 | 0.090 |
Why?
| | Trachea | 1 | 2011 | 225 | 0.090 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2009 | 113 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2011 | 418 | 0.080 |
Why?
| | Epithelial Cells | 3 | 2021 | 951 | 0.080 |
Why?
| | Bone Marrow | 1 | 2009 | 252 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2021 | 2664 | 0.080 |
Why?
| | Cystic Fibrosis | 1 | 2014 | 963 | 0.060 |
Why?
| | Angiopoietins | 1 | 2022 | 14 | 0.060 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 35 | 0.050 |
Why?
| | Fingolimod Hydrochloride | 1 | 2022 | 30 | 0.050 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2022 | 62 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2018 | 2012 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 240 | 0.050 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 10 | 0.050 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 10 | 0.050 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 55 | 0.050 |
Why?
| | CD11 Antigens | 1 | 2021 | 28 | 0.050 |
Why?
| | Cell Size | 1 | 2021 | 83 | 0.050 |
Why?
| | CD11b Antigen | 1 | 2021 | 57 | 0.050 |
Why?
| | Lectins | 1 | 2021 | 49 | 0.050 |
Why?
| | Adult | 4 | 2017 | 31327 | 0.050 |
Why?
| | Hepatocyte Growth Factor | 1 | 2019 | 33 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 504 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 282 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 466 | 0.040 |
Why?
| | Pulmonary Surfactants | 1 | 2019 | 98 | 0.040 |
Why?
| | NF-kappa B | 1 | 2022 | 664 | 0.040 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 42 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2019 | 354 | 0.040 |
Why?
| | Autophagy | 1 | 2019 | 312 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1142 | 0.030 |
Why?
| | Gene Expression | 1 | 2021 | 1482 | 0.030 |
Why?
| | Cell Survival | 1 | 2018 | 1045 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1202 | 0.030 |
Why?
| | Binding, Competitive | 1 | 2015 | 204 | 0.030 |
Why?
| | Homeostasis | 1 | 2018 | 589 | 0.030 |
Why?
| | Hexuronic Acids | 1 | 2014 | 30 | 0.030 |
Why?
| | Polysaccharide-Lyases | 1 | 2014 | 13 | 0.030 |
Why?
| | Glucuronic Acid | 1 | 2014 | 33 | 0.030 |
Why?
| | Virulence | 1 | 2014 | 239 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1338 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2022 | 2435 | 0.030 |
Why?
| | Protein Binding | 1 | 2018 | 1969 | 0.030 |
Why?
| | Signal Transduction | 2 | 2018 | 4688 | 0.030 |
Why?
| | Contractile Proteins | 1 | 2011 | 17 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2011 | 37 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2011 | 64 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1288 | 0.020 |
Why?
| | Hypertrophy | 1 | 2011 | 121 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2011 | 82 | 0.020 |
Why?
| | Bone Marrow Examination | 1 | 2009 | 7 | 0.020 |
Why?
| | Histoplasma | 1 | 2009 | 13 | 0.020 |
Why?
| | Dogs | 1 | 2011 | 369 | 0.020 |
Why?
| | Amphotericin B | 1 | 2009 | 30 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2010 | 306 | 0.020 |
Why?
| | Lymph Node Excision | 1 | 2010 | 158 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2011 | 236 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2011 | 810 | 0.020 |
Why?
| | Antifungal Agents | 1 | 2009 | 134 | 0.020 |
Why?
| | Actins | 1 | 2011 | 400 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2014 | 744 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2011 | 413 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2010 | 443 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6368 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2010 | 1221 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1622 | 0.020 |
Why?
| | Biopsy | 1 | 2009 | 1078 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2011 | 2262 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2477 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2010 | 4575 | 0.010 |
Why?
| | Asthma | 1 | 2011 | 2143 | 0.010 |
Why?
| | Aged | 1 | 2012 | 19599 | 0.010 |
Why?
|
|
Serban's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|